Loading...
AXL/AKT axis mediated-resistance to BRAF inhibitor depends on PTEN status in melanoma
Multiple genetic mutations within melanoma not only cause lesion-specific responses to targeted therapy but also alter the molecular route of resistance to that therapy. Inactivation of PTEN occurs in up to 30% of melanomas, frequently with a concurrent activating BRAF mutation. PTEN loss regulates...
Na minha lista:
| Udgivet i: | Oncogene |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6508599/ https://ncbi.nlm.nih.gov/pubmed/29551771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-018-0205-4 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|